226 related articles for article (PubMed ID: 28299853)
1. The effect of a beta-lactamase inhibitor peptide on bacterial membrane structure and integrity: a comparative study.
Alaybeyoglu B; Uluocak BG; Akbulut BS; Ozkirimli E
J Pept Sci; 2017 May; 23(5):374-383. PubMed ID: 28299853
[TBL] [Abstract][Full Text] [Related]
2. A novel chimeric peptide with antimicrobial activity.
Alaybeyoglu B; Akbulut BS; Ozkirimli E
J Pept Sci; 2015 Apr; 21(4):294-301. PubMed ID: 25597294
[TBL] [Abstract][Full Text] [Related]
3. pVEC hydrophobic N-terminus is critical for antibacterial activity.
Alaybeyoglu B; Sariyar Akbulut B; Ozkirimli E
J Pept Sci; 2018 Jun; 24(6):e3083. PubMed ID: 29737576
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial activities and action mechanism studies of transportan 10 and its analogues against multidrug-resistant bacteria.
Xie J; Gou Y; Zhao Q; Li S; Zhang W; Song J; Mou L; Li J; Wang K; Zhang B; Yang W; Wang R
J Pept Sci; 2015 Jul; 21(7):599-607. PubMed ID: 25891396
[TBL] [Abstract][Full Text] [Related]
5. [Antibacterial activity of beta-lactam antibiotics against extended-spectrum beta-lactamase producing bacteria].
Kuga A; Yano H; Okamoto R; Sato Y; Miyata A; Inoue M
Jpn J Antibiot; 1999 Sep; 52(9):585-94. PubMed ID: 10746193
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity, bactericidal mechanism and LPS-neutralizing activity of the cell-penetrating peptide pVEC and its analogs.
Nan YH; Park IS; Hahm KS; Shin SY
J Pept Sci; 2011 Dec; 17(12):812-7. PubMed ID: 21956793
[TBL] [Abstract][Full Text] [Related]
7. Stigmasterol: An adjuvant for beta lactam antibiotics against beta-lactamase positive clinical isolates.
Yenn TW; Arslan Khan M; Amiera Syuhada N; Chean Ring L; Ibrahim D; Tan WN
Steroids; 2017 Dec; 128():68-71. PubMed ID: 29104098
[TBL] [Abstract][Full Text] [Related]
8. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
Weston GS; Blázquez J; Baquero F; Shoichet BK
J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
[TBL] [Abstract][Full Text] [Related]
9. Variants of β-lactamase KPC-2 that are resistant to inhibition by avibactam.
Papp-Wallace KM; Winkler ML; Taracila MA; Bonomo RA
Antimicrob Agents Chemother; 2015 Jul; 59(7):3710-7. PubMed ID: 25666153
[TBL] [Abstract][Full Text] [Related]
10. Multistep optimization of a cell-penetrating peptide towards its antimicrobial activity.
Drexelius M; Reinhardt A; Grabeck J; Cronenberg T; Nitsche F; Huesgen PF; Maier B; Neundorf I
Biochem J; 2021 Jan; 478(1):63-78. PubMed ID: 33313751
[TBL] [Abstract][Full Text] [Related]
11. Beta-lactamase patterns and betalactam/clavulanic acid resistance in Escherichia coli isolated from fecal samples from healthy volunteers.
Gulay Z; Bicmen M; Amyes SG; Yulug N
J Chemother; 2000 Jun; 12(3):208-15. PubMed ID: 10877515
[TBL] [Abstract][Full Text] [Related]
12. An in vitro evaluation of clavulanic acid, a potent, broad-spectrum beta-lactamase inhibitor.
Greenwood D; O'Grady F; Baker P
J Antimicrob Chemother; 1979 Sep; 5(5):539-47. PubMed ID: 387706
[TBL] [Abstract][Full Text] [Related]
13. Recombinant expression, antimicrobial activity and mechanism of action of tritrpticin analogs containing fluoro-tryptophan residues.
Arias M; Hoffarth ER; Ishida H; Aramini JM; Vogel HJ
Biochim Biophys Acta; 2016 May; 1858(5):1012-23. PubMed ID: 26724205
[TBL] [Abstract][Full Text] [Related]
14. Avibactam and inhibitor-resistant SHV β-lactamases.
Winkler ML; Papp-Wallace KM; Taracila MA; Bonomo RA
Antimicrob Agents Chemother; 2015 Jul; 59(7):3700-9. PubMed ID: 25691639
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activities and membrane-active mechanism of CPF-C1 against multidrug-resistant bacteria, a novel antimicrobial peptide derived from skin secretions of the tetraploid frog Xenopus clivii.
Xie J; Gou Y; Zhao Q; Wang K; Yang X; Yan J; Zhang W; Zhang B; Ma C; Wang R
J Pept Sci; 2014 Nov; 20(11):876-84. PubMed ID: 25098547
[TBL] [Abstract][Full Text] [Related]
16. The complexed structure and antimicrobial activity of a non-beta-lactam inhibitor of AmpC beta-lactamase.
Powers RA; Blázquez J; Weston GS; Morosini MI; Baquero F; Shoichet BK
Protein Sci; 1999 Nov; 8(11):2330-7. PubMed ID: 10595535
[TBL] [Abstract][Full Text] [Related]
17. Binding properties of a peptide derived from beta-lactamase inhibitory protein.
Rudgers GW; Huang W; Palzkill T
Antimicrob Agents Chemother; 2001 Dec; 45(12):3279-86. PubMed ID: 11709298
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial properties of membrane-active dodecapeptides derived from MSI-78.
Monteiro C; Fernandes M; Pinheiro M; Maia S; Seabra CL; Ferreira-da-Silva F; Costa F; Reis S; Gomes P; Martins MC
Biochim Biophys Acta; 2015 May; 1848(5):1139-46. PubMed ID: 25680229
[TBL] [Abstract][Full Text] [Related]
19. Insights into membrane translocation of the cell-penetrating peptide pVEC from molecular dynamics calculations.
Alaybeyoglu B; Sariyar Akbulut B; Ozkirimli E
J Biomol Struct Dyn; 2016 Nov; 34(11):2387-98. PubMed ID: 26569019
[TBL] [Abstract][Full Text] [Related]
20. Cell penetrating synthetic antimicrobial peptides (SAMPs) exhibiting potent and selective killing of mycobacterium by targeting its DNA.
Sharma A; Pohane AA; Bansal S; Bajaj A; Jain V; Srivastava A
Chemistry; 2015 Feb; 21(9):3540-5. PubMed ID: 25608020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
